18F-FDG PET/CT can be used to detect non-functioning pancreatic neuroendocrine tumors

  • Authors:
    • Guopei Luo
    • Zuqiang Liu
    • Meng Guo
    • Kaizhou Jin
    • Zhiwen Xiao
    • Liang Liu
    • Jin Xu
    • Bo Zhang
    • Chen Liu
    • Dan Huang
    • Silong Hu
    • Quanxing Ni
    • Jiang Long
    • Xianjun Yu
  • View Affiliations

  • Published online on: July 29, 2014     https://doi.org/10.3892/ijo.2014.2570
  • Pages: 1531-1536
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

18F-Fluorodeoxyglucose positron emission tomo-graphy and computed tomography (18F-FDG PET/CT) has limited value in well-differentiated neuroendocrine tumors. The value of 18F-FDG PET/CT in non-functioning pancreatic neuroendocrine tumors, which are often poorly differentiated, malignant, and present at an advanced stage, was also thought to be limited. This study was performed to evaluate the clinical value of 18F-FDG PET/CT in assessing non-functioning pancreatic neuroendocrine tumors. From January 2010 to February 2014, a comparable large cohort of patients (31 cases) with non-functioning pancreatic neuroendocrine tumors from Shanghai Cancer Center underwent 18F-FDG PET/CT scans. Demographics and clinical characteristics were retrospectively collected and analyzed for all the patients. Twenty-eight of 31 (90.3%) patients with non-functioning endocrine pancreatic tumors had an elevated 18F-FDG uptake (SUVmax ≥2.5). In addition, 18F-FDG PET/CT visualized 38 of 42 (90.5%) distant metastatic lesions. The 18F-FDG uptake had significant association with tumor size (P=0.012) and TNM stage (P=0.004). The application of 18F-FDG PET/CT has changed the management of 8 cases (8/31, 25.8%). In conclusion, 18F‑FDG PET/CT plays an important role in detecting and staging non-functioning pancreatic neuroendocrine tumors.
View Figures
View References

Related Articles

Journal Cover

October 2014
Volume 45 Issue 4

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Luo, G., Liu, Z., Guo, M., Jin, K., Xiao, Z., Liu, L. ... Yu, X. (2014). 18F-FDG PET/CT can be used to detect non-functioning pancreatic neuroendocrine tumors. International Journal of Oncology, 45, 1531-1536. https://doi.org/10.3892/ijo.2014.2570
MLA
Luo, G., Liu, Z., Guo, M., Jin, K., Xiao, Z., Liu, L., Xu, J., Zhang, B., Liu, C., Huang, D., Hu, S., Ni, Q., Long, J., Yu, X."18F-FDG PET/CT can be used to detect non-functioning pancreatic neuroendocrine tumors". International Journal of Oncology 45.4 (2014): 1531-1536.
Chicago
Luo, G., Liu, Z., Guo, M., Jin, K., Xiao, Z., Liu, L., Xu, J., Zhang, B., Liu, C., Huang, D., Hu, S., Ni, Q., Long, J., Yu, X."18F-FDG PET/CT can be used to detect non-functioning pancreatic neuroendocrine tumors". International Journal of Oncology 45, no. 4 (2014): 1531-1536. https://doi.org/10.3892/ijo.2014.2570